Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TBPH Theravance Biopharma Inc.

交易中 01-13 15:18:11 EST

20.39

+0.74

+3.74%

最高20.43	最低19.17	成交量21.24万
今开19.63	昨收19.65	日振幅6.41%
总市值10.33亿	流通市值4.45亿	总股本5,067万
成交额422.17万	换手率0.97%	流通股本2,184万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TBPH","market":"US","secType":"STK","nameCN":"Theravance Biopharma Inc.","latestPrice":20.385,"timestamp":1768335487089,"preClose":19.65,"halted":0,"volume":212357,"delay":0,"floatShares":21844151,"shares":50672431,"eps":0.580292,"marketStatus":"交易中","change":0.735,"latestTime":"01-13 15:18:11 EST","open":19.63,"high":20.43,"low":19.17,"amount":4221674.14856,"amplitude":0.064122,"askPrice":20.4,"askSize":414,"bidPrice":20.37,"bidSize":123,"shortable":3,"etf":0,"ttmEps":0.580292,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1400212800000,"exchange":"NASDAQ","adjPreClose":19.65,"preHourTrading":{"tag":"盘前","latestPrice":19.6539,"preClose":19.65,"latestTime":"08:27 EST","volume":300,"amount":5896.17,"timestamp":1768310840666},"postHourTrading":{"tag":"盘后","latestPrice":19.65,"preClose":19.65,"latestTime":"17:59 EST","volume":6437,"amount":126486.6,"timestamp":1768258795134},"volumeRatio":0.542045,"impliedVol":0.8222,"impliedVolPercentile":0.8805},"requestUrl":"/m/hq/s/TBPH","defaultTab":"news","newsList":[{"id":"1113644214","title":"Theravance Biopharma第三季度经营收入为-645.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113644214","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113644214?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:20","pubTimestamp":1763572813,"startTime":"0","endTime":"0","summary":"11月10日 - Theravance Biopharma第三季度收入为1999万美元，比IBES预估的1930万美元略高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"1124399899","title":"Theravance Biopharma启动疾病教育活动 以推进对多系统萎缩引起的神经性直立性低血压的科学理解","url":"https://stock-news.laohu8.com/highlight/detail?id=1124399899","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124399899?lang=zh_cn&edition=full","pubTime":"2025-10-16 20:07","pubTimestamp":1760616432,"startTime":"0","endTime":"0","summary":"Theravance Biopharma启动疾病教育活动，以推进对多系统萎缩引起的神经性直立性低血压的科学理解","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"1135946590","title":"Theravance Biopharma完成关键性3期Cypress研究入组，该研究评估安普洛西汀治疗多系统萎缩引起的症状性神经源性直立性低血压","url":"https://stock-news.laohu8.com/highlight/detail?id=1135946590","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135946590?lang=zh_cn&edition=full","pubTime":"2025-08-25 18:04","pubTimestamp":1756116246,"startTime":"0","endTime":"0","summary":"Theravance Biopharma已完成其关键性3期Cypress研究的患者入组工作。该研究旨在评估安普洛西汀在治疗由多系统萎缩引起的症状性神经源性直立性低血压患者中的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"1166783428","title":"Theravance Biopharma：预计2026年第一季度公布顶线结果，若成功将计划加速提交新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1166783428","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166783428?lang=zh_cn&edition=full","pubTime":"2025-08-25 18:03","pubTimestamp":1756116219,"startTime":"0","endTime":"0","summary":"Theravance Biopharma表示，预计将在2026年第一季度公布顶线结果，如果试验成功，公司计划加速提交新药申请(NDA)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2517427629","title":"Theravance Biopharma, Inc.盘中异动 大幅拉升5.16%报9.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517427629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517427629?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:20","pubTimestamp":1741195237,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时20分，Theravance Biopharma, Inc.股票出现波动，股价急速拉升5.16%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为933.95%、303.15%、289.83%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306012037989d6bab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306012037989d6bab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2516754802","title":"Theravance Biopharma, Inc.2024财年实现净利润-56.42百万美元，同比减少2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516754802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516754802?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931279,"startTime":"0","endTime":"0","summary":"3月3日，Theravance Biopharma, Inc.公布财报，公告显示公司2024财年净利润为-56.42百万美元，同比减少2.23%；其中营业收入为64.38百万美元，同比增加12.12%，每股基本收益为-1.16美元。机构评级：截至2025年3月3日，当前有4家机构对Theravance Biopharma, Inc.目标价做出预测，其中目标均价为14.50美元，其中最低目标价为10.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000156a25bbc84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000156a25bbc84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH"],"gpt_icon":0},{"id":"2514385130","title":"Theravance Biopharma, Inc.盘中异动 股价大涨8.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385130?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666678,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，Theravance Biopharma, Inc.股票出现异动，股价急速上涨8.81%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Quoin Pharmaceuticals Ltd、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为394.03%、90.29%、48.43%，振幅较大的相关个股有天演药业、Syros Pharmaceuticals, Inc.、内克塔治疗，振幅分别为10.10%、10.09%、7.64%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223118abdf6e6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223118abdf6e6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"1107161536","title":"Theravance Biopharma 第四季度调整后EPS $(0.05) 优于预期 $(0.21)，销售额 $1875万 超预期 $1709万","url":"https://stock-news.laohu8.com/highlight/detail?id=1107161536","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107161536?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:33","pubTimestamp":1740605625,"startTime":"0","endTime":"0","summary":"Theravance Biopharma  公布季度每股亏损 $，比分析师一致预期的 $ 高出76.19%。这比去年同期每股亏损 $ 增加了70.59%。以上内容来自Benzinga Earnings专栏，原文如下：Theravance Biopharma  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 76.19 percent. This is a 70.59 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $18.75 million which beat the analyst consensus estimate of $17.09 million by 9.73 percent.  This is a 6.77 percent increase over s","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Theravance Biopharma 第四季度调整后EPS $(0.05) 优于预期 $(0.21)，销售额 $1875万 超预期 $1709万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBPH"],"gpt_icon":0},{"id":"2514705216","title":"Theravance Biopharma, Inc.盘中异动 临近收盘急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514705216?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:55","pubTimestamp":1740430544,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时55分，Theravance Biopharma, Inc.股票出现波动，股价大幅下挫5.05%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为332.71%、145.46%、41.78%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、164.23%、81.92%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504554498913f99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022504554498913f99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2506309225","title":"Theravance Biopharma, Inc.盘中异动 急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506309225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506309225?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:14","pubTimestamp":1737990865,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时14分，Theravance Biopharma, Inc.股票出现波动，股价快速下跌5.16%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1714.17%、188.57%、164.70%，振幅较大的相关个股有阿诺医药、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为98.54%、85.35%、65.16%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012723142696124086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012723142696124086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2506908860","title":"Theravance Biopharma, Inc.盘中异动 早盘股价大涨6.51%报10.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506908860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506908860?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:19","pubTimestamp":1737735568,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时19分，Theravance Biopharma, Inc.股票出现波动，股价快速拉升6.51%。截至发稿，该股报10.30美元/股，成交量8.9241万股，换手率0.18%，振幅5.44%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125001929a22e7240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125001929a22e7240&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2505205340","title":"Theravance Biopharma, Inc.盘中异动 急速拉升5.01%报9.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505205340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505205340?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:16","pubTimestamp":1737476195,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时16分，Theravance Biopharma, Inc.股票出现异动，股价快速拉升5.01%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。其相关个股中，Channel Therapeutics Corporation、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dogwood Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为755.88%、472.32%、182.27%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001635986e4695&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122001635986e4695&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2484979041","title":"Theravance Biopharma, Inc.盘中异动 股价大涨5.06%报9.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484979041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484979041?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:41","pubTimestamp":1732041679,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时41分，Theravance Biopharma, Inc.股票出现波动，股价快速上涨5.06%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.33%。其相关个股中，Syros Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Syros Pharmaceuticals, Inc.、Tff Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为1019.69%、836.68%、141.70%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为91.10%、81.67%、62.82%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112002411998e4391e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112002411998e4391e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2483300884","title":"Theravance Biopharma, Inc.盘中异动 早盘快速上涨6.29%报9.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483300884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483300884?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508275,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Theravance Biopharma, Inc.股票出现异动，股价快速拉升6.29%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Kairos Pharma, Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为323.85%、168.31%、84.06%，振幅较大的相关个股有Entero Therapeutics Inc.、Turnstone Biologics Corp.、Cyclacel Pharmaceuticals, Inc.，振幅分别为8.29%、7.65%、7.63%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322311595be230e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322311595be230e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2481939798","title":"Theravance Biopharma, Inc.盘中异动 股价大涨5.14%报8.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481939798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481939798?lang=zh_cn&edition=full","pubTime":"2024-11-07 02:02","pubTimestamp":1730916162,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日02时02分，Theravance Biopharma, Inc.股票出现波动，股价急速上涨5.14%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Sonnet Biotherapeutics Holdings, Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为3021.40%、425.92%、133.19%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc.、Sonnet Biotherapeutics Holdings, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为82.72%、77.67%、57.62%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107020242a21d9460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107020242a21d9460&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2475667712","title":"Theravance Biopharma, Inc.盘中异动 大幅拉升6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475667712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475667712?lang=zh_cn&edition=full","pubTime":"2024-10-16 03:48","pubTimestamp":1729021733,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日03时48分，Theravance Biopharma, Inc.股票出现波动，股价快速上涨6.01%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Bright Minds Biosciences Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Bright Minds Biosciences Inc.、Salarius Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为2154.74%、501.88%、413.94%，振幅较大的相关个股有Bright Minds Biosciences Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为1204.82%、173.40%、123.44%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101603485398e3c9dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101603485398e3c9dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.theravance.com","stockEarnings":[{"period":"1week","weight":0.0668},{"period":"1month","weight":0.0815},{"period":"3month","weight":0.4188},{"period":"6month","weight":0.6867},{"period":"1year","weight":1.238},{"period":"ytd","weight":0.0502}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Theravance Biopharma, Inc.，于2013年7月注册为开曼群岛豁免股份有限公司。该公司是一家生物制药公司，主要专注于药物的发现、开发和商业化。该公司的核心宗旨是创造能够改变人们生活的药物。该公司利用数十年的专业知识，开发了FDA批准的YUPELRI（revefenacin）吸入溶液，用于慢性阻塞性肺病患者的维持治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.016646},{"month":2,"riseRate":0.272727,"avgChangeRate":0.009876},{"month":3,"riseRate":0.363636,"avgChangeRate":0.007997},{"month":4,"riseRate":0.545455,"avgChangeRate":0.039762},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.069476},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.023379},{"month":7,"riseRate":0.416667,"avgChangeRate":0.004568},{"month":8,"riseRate":0.666667,"avgChangeRate":0.01951},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.030285},{"month":10,"riseRate":0.5,"avgChangeRate":-0.025542},{"month":11,"riseRate":0.75,"avgChangeRate":0.113018},{"month":12,"riseRate":0.583333,"avgChangeRate":0.041602}],"exchange":"NASDAQ","name":"Theravance Biopharma Inc.","nameEN":"Theravance Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Theravance Biopharma Inc.(TBPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Theravance Biopharma Inc.,TBPH,Theravance Biopharma Inc.股票,Theravance Biopharma Inc.股票老虎,Theravance Biopharma Inc.股票老虎国际,Theravance Biopharma Inc.行情,Theravance Biopharma Inc.股票行情,Theravance Biopharma Inc.股价,Theravance Biopharma Inc.股市,Theravance Biopharma Inc.股票价格,Theravance Biopharma Inc.股票交易,Theravance Biopharma Inc.股票购买,Theravance Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Theravance Biopharma Inc.(TBPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}